Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)
Clinical trial NCT04515641 · COMPLETED
Trial details
- NCT number
- NCT04515641
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-05
- Primary completion
- 2021-09-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.